US Neurology Editor-in-Chief, Said Beydoun (Keck Medical Center of USC, University of Southern California, CA, USA), discusses emerging therapies for the management of myasthenia gravis.
Questions
- What have been the major findings of the MGTX randomised study of thymectomy in myasthenia gravis? (0:04)
- Which patients are most likely to benefit from thymectomy? (2:13)
- Which other emerging therapies seem promising in the treatment of myasthenia gravis? (3:27)
View Part 1 of this expert interview here.
Speaker disclosures: Said Beydoun has received research grants from Argenx, Catalyst and UCB, and is a consultant, advisory board member and speaker for Alexion.
Filmed at the American Academy of Neurology (AAN) Annual Meeting, Philadelphia, USA, May 2019.
